Advertisement
Screener

BIOVENTUS INC. (BVS) Proceeds from Issuance of Other Long-term Debt

2.2 / 5 stars · 24/55 Roast Me

BIOVENTUS INC. Proceeds from Issuance of Other Long-term Debt

BIOVENTUS INC. (BVS) reported Proceeds from Issuance of Other Long-term Debt of $31.91 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt · last filed 2026-03-05

  • BIOVENTUS INC. proceeds from issuance of other long-term debt for the quarter ending 2023-12-31 was $0.00.
  • BIOVENTUS INC. proceeds from issuance of other long-term debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
  • BIOVENTUS INC. proceeds from issuance of other long-term debt for the quarter ending 2021-12-31 was $257.45M.
  • BIOVENTUS INC. proceeds from issuance of other long-term debt for fiscal 2025 was $31.91M.
  • BIOVENTUS INC. proceeds from issuance of other long-term debt for fiscal 2024 was $0.00.
  • BIOVENTUS INC. proceeds from issuance of other long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • BIOVENTUS INC. proceeds from issuance of other long-term debt for fiscal 2022 was $79.66M, a 69.06% decline from fiscal 2021.
Period endProceeds from Issuance of Other Long-term Debt 3 monthProceeds from Issuance of Other Long-term Debt 9 monthProceeds from Issuance of Other Long-term Debt 12 month
2025-12-31$31.91M
10-K · filed 2026-03-05
2024-12-31$0.00
10-K · filed 2026-03-05
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$0.00
10-K · filed 2026-03-05
2023-09-30$0.00
10-Q · filed 2023-11-07
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$79.66M
10-K · filed 2025-03-11
2022-10-01$79.66M
10-Q · filed 2023-11-07
2021-12-31$257.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
$257.45M
10-K · filed 2024-03-12
2021-10-02$0.00
10-Q · filed 2022-11-21
2020-12-31$0.00
10-K · filed 2023-03-31
2019-12-31$198.13M
10-K · filed 2022-03-11